B1INP5 (BXB_CLOBK) Clostridium botulinum (strain Okra / Type B1)
Botulinum neurotoxin type B UniProtKBInterProInteractive Modelling
1291 aa; Sequence (Fasta) ;
2 identical sequences: Clostridium botulinum B: Q33CP3; Clostridium botulinum: P10844
It is possible new templates exist for this target since these models were created.
Available Structures
34 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of an engineered Botulinum Neurotoxin type B mutant E1191M/S1199Y in complex with… |
Heteromer P10844; Q8N9I0; | 1×MG; 1×EDO; 2×PEG; 1×TRS; 1×ACT; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of an engineered Botulinum Neurotoxin type B mutant E1191M/S1199Y in complex with… |
Heteromer P10844; P21579; | 3×GOL; 1×MLI; | ||||
| Assess | ||||||
| Crystal structure of the Botulinum neurotoxin type B complexed with synaptotagamin-II ectodomain |
Heteromer P10844; P46097; | 1×ZN; 3×CA; 1×CL; | ||||
| Assess | ||||||
| Structure of a functional derivative of Clostridium botulinum neurotoxin type B |
Heteromer P10844; | 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of BoNT/B-LC-JSG-C1 |
Heteromer P10844; | 3×EDO; 1×ZN; | ||||
| Assess | ||||||
| Structure of BoNT/B in complex with its protein receptor |
Heteromer P10844; P29101; | |||||
| Assess | ||||||
| Crystal structure of BoNT/B receptor-binding domain in complex with VHH JLI-G10 |
Heteromer P10844; | |||||
| Assess | ||||||
| Receptor binding domain of BoNT/B in complex with mini-protein binder Bot.2110.4 |
Heteromer P10844; | |||||
| Assess | ||||||
| Crystal structure of the binding domain of Botulinum Neurotoxin type B in complex with human synapt… |
Heteromer P10844; P21579; | |||||
| Assess | ||||||
| Crystal structure of BoNT/B receptor-binding domain in complex with VHH JLO-G11 |
Heteromer P10844; | |||||
| Assess | ||||||
| Structure of Botulinum neurotoxin B binding domain in complex with both synaptotagmin II and GD1a |
Heteromer P10844; P46097; | 1×BGC; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of BoNT/B receptor-binding domain in complex with VHH JLI-H11 |
Heteromer P10844; | |||||
| Assess | ||||||
| Crystal structure of the binding domain of Botulinum Neurotoxin type B mutant I1248W/V1249W in comp… |
Heteromer P10844; P21579; | 1×BGC; | ||||
| Assess | ||||||
| Crystal structure of BoNT/B receptor-binding domain in complex with VHH JLK-G12 |
Heteromer P10844; | 2×SO4; | ||||
| Assess | ||||||
| Receptor binding domain of BoNT/B in complex with mini-protein binder Bot.0671.2 |
Heteromer P10844; | |||||
| Assess | ||||||
| Botulinum neurotoxin Type B Light Chain complexed with nanobodies JLJ-G3 and JNE-B10 |
Heteromer P10844; | 1×ZN; 4×IOD; | ||||
| Assess | ||||||
| Cryo-EM structure of Botulinum neurotoxin serotype B | monomer | |||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B at pH 6.0 | monomer | 1×ZN; 2×CA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B | monomer | 1×ZN; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B at pH 4.0 | monomer | 2×CA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1) | monomer | 2×ZN; 2×BAB; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3) | monomer | 2×ZN; 2×BAB; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2) | monomer | 2×ZN; 2×BAB; | ||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B at pH 5.5 | monomer | 1×ZN; 2×CA; | ||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B at pH 5.0 | monomer | 1×ZN; 2×CA; | ||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B at pH 7.0 | monomer | 1×ZN; 2×CA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4) | monomer | 2×ZN; 2×BAB; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN | monomer | 1×DM2; 1×ZN; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of botulinum neurotoxin type B apo form | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE | monomer | 1×GLC; 1×ZN; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of an engineered botulinum neurotoxin type B - derivative, LC-B-GS-Hn-B | monomer | 1×ZN; | ||||
| Assess | ||||||
| N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B | monomer | |||||
| Assess | ||||||
| Crystal structure of full length botulinum neurotoxin (Type B) light chain | monomer | 1×ZN; 1×SO4; | ||||
| Assess | ||||||
| BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN | monomer | 1×ZN; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2np0.2.A | monomer | 0.85 | 1×ZN; 3×CA; | 100.00 | ||
| Assess | ||||||
| 3v0a.1.A | monomer | 0.68 | 39.25 | |||
| Assess | ||||||